TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Opyl Ltd. ( (AU:PKY) ) has provided an update.
Pathkey.AI Ltd has announced that its Annual General Meeting (AGM) will take place on November 26, 2025, with the re-election of Directors as a key agenda item. The deadline for director nominations is set for October 8, 2025. This meeting is crucial for the company’s governance and strategic direction, impacting its operations and stakeholder engagement.
More about Opyl Ltd.
Pathkey.AI Limited is an Australian technology company specializing in artificial intelligence solutions to enhance the efficiency, success, and transparency of clinical trials. Their core platform, TrialKey, is an AI-powered decision-support tool designed to predict the success probability of clinical trials and optimize trial design and planning. The company aims to transform drug development by reducing risk, improving resource allocation, and fostering data-driven innovation in the life sciences sector.
Average Trading Volume: 895,897
Technical Sentiment Signal: Hold
Current Market Cap: A$7.87M
See more data about PKY stock on TipRanks’ Stock Analysis page.